Sialidase and malignancy: a minireview.
Aberrant sialylation in cancer cells is thought to be a characteristic feature associated with malignant properties including invasiveness and metastatic potential. Sialidase which catalyzes the removal of sialic acid residues from glycoproteins and glycolipids, has been suggested to play important roles in many biological processes through regulation of cellular sialic acid contents. The altered expression of sialidase observed in cancer would, therefore, suggest its involvement in the malignant process. In mammalian cells, three types of sialidase cloned and characterized to date were found to behave in different manners during carcinogenesis. Recent progress in molecular cloning of these sialidases has facilitated elucidation of the molecular mechanisms and significance of these alterations. Herein we briefly describe our own studies on sialidase changes associated with malignant transformation and summarize the topic from both a retrospective and a prospective viewpoint. Sialidases are indeed closely related to malignancy and are thus potential targets for cancer diagnosis and therapy.
Miyagi
Taeko
T
Division of Biochemistry, Research Institute, Miyagi Prefectural Cancer Center, Natori, Miyagi 981-1293, Japan. tmiyagi@mcc.pref.miyagi.jp
Wada
Tadashi
T
Yamaguchi
Kazunori
K
Hata
Keiko
K
D000818:Animals; D006801:Humans; D019158:N-Acetylneuraminic Acid / Q000378:metabolism; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology*; D009439:Neuraminidase / Q000235:genetics / Q000378:metabolism*
D009439:Neuraminidase; D019158:N-Acetylneuraminic Acid